About Dr. Santini
Dr. Santini is a serial entrepreneur and scientist that has spent his career focused on the creation and growth of businesses developing next-generation pharmaceuticals, drug delivery systems, biosensors, and mobile health products.
Prior to co-founding ApoGen Biotechnologies, he served as the CEO or CTO of four healthcare startups – MicroCHIPS, On Demand Therapeutics, RadioRx, and IRISense – developing products such as novel cancer therapeutics, laser-activated anti-VEGF implants for eye diseases, wireless implantable drug delivery and biosensor systems for osteoporosis and diabetes, and smartphone-based sensing systems for diabetes management.
Dr. Santini has been honored as one of Popular Science Magazine’s “Brilliant Ten” and one of the Top 100 Young Innovators in the world by Technology Review Magazine. He has over 60 issued US and international patents, and his work resulted in a Technology Pioneer award from the World Economic Forum (Davos, Switzerland) and a Gold Medal from the Edison Awards in the Science and Medical, Game Changers category.